Fibromyalgia Treatment: A Leading Driver Behind Government Initiatives On Musculoskeletal Health Propel Growth In The Fibromyalgia Market Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Fibromyalgia Treatment Industry Market Size Be by 2025?
In the past few years, the market size for the treatment of fibromyalgia has been on a progressive rise. It is predicted to increase from $2.79 billion in 2024 to $2.9 billion in 2025, registering a compound annual growth rate (CAGR) of 3.9%. This growth during the historic period can be credited to factors such as a rise in the occurrence of fibromyalgia, enhanced awareness about the condition, government initiatives, and increased disposable incomes.

What's the Long-Term Growth Forecast for the Fibromyalgia Treatment Market Size Through 2029?
In the upcoming years, the market size for fibromyalgia treatment is predicted to witness stable expansion. By 2029, the market is anticipated to be worth $3.45 billion, growing at a compound annual growth rate (CAGR) of 4.5%. The growth observed during the forecast period can be credited to the increasing aging population, an upward trend in healthcare spending, a growing number of musculoskeletal disorders, and increased R&D activities aimed at discovering improved treatments. The period is also expected to see evolving trends such as enhancements in treatment alternatives, strategic partnerships, progress in technology integration, and innovative treatment methods.

View the full report here:
https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

What Are the Key Growth Drivers Fueling the Fibromyalgia Treatment Market Expansion?
The future growth of the fibromyalgia market is projected to be accelerated by increased governmental actions directed at musculoskeletal conditions. Government initiatives allude to certain actions, policies, or programs initiated by the government to tackle societal issues, boost economic development, enhance public services, or meet specific objectives that are beneficial to the country and its people. Key government bodies are putting forth numerous initiatives to assist those dealing with musculoskeletal conditions. For example, in 2022, as stated by Musculoskeletal Australia, an Australian organization, the Own Your Health initiative was implemented by the Australian government. The aim of this initiative is to encourage comprehensive self-care for patients with musculoskeletal conditions over the following four years. Therefore, expanded government initiatives on musculoskeletal conditions stimulate the fibromyalgia market. The rise in the elderly population is seen as a significant factor propelling the growth of the fibromyalgia treatment market. An aging population is a demographic trend identified by an increasing number of older individuals in a society or population. The aging population can benefit significantly from fibromyalgia treatment as they are more prone to developing fibromyalgia and often suffer from more intense symptoms due to aging-related factors. For example, in July 2022, as reported by the United Nations Department of Economic and Social Affairs, a US-based agency, the percentage of the world's population aged 65 and over is anticipated to rise from 10% in 2022 to 16% by 2050. Therefore, the increase in the aging population propels the expansion of the fibromyalgia treatment market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12933&type=smp

What Are the Key Trends Driving Fibromyalgia Treatment Market Growth?
Leading firms in the fibromyalgia treatment market are concentrating their efforts on creating technologically innovative solutions like microchip technology to maintain their market standing. Specific proprietary microchip technology works by employing a microchip for exact nerve stimulation, which helps lessen fibromyalgia-related symptoms. An example of this is the Quell Fibromyalgia device introduced in November 2022 by NeuroMetrix Inc., a medical equipment manufacturer based in the US. They launched this through the Pathfinder Program as an innovative approach to reducing fibromyalgia symptoms. The Quell Fibromyalgia device, the sole medical instrument approved by the FDA for fibromyalgia symptom mitigation, uses transcutaneous electrical nerve stimulation (TENS). This device's effectiveness is heightened with proprietary microchip technology, providing accurate, high-powered nerve stimulation in a compact, wearable form, and further improved by position and motion sensing.

How Is the Fibromyalgia Treatment Market Segmented?
The fibromyalgia treatment market covered in this report is segmented -

1) By Type: Symptomatic Treatment, Targeted Treatment
2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:
1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy
2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12933&type=smp

Which Companies Are Leading the Charge in Fibromyalgia Treatment Market Innovation?
Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Horizon Therapeutics PLC, Endo International PLC, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited.

Which Regions Are Leading the Global Fibromyalgia Treatment Market in Revenue?
North America was the largest region in the fibromyalgia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in fibromyalgia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12933

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.